Hisamitsu Pharmaceutical Co. ( OTCPK:HTSUF ) subsidiary Noven Pharmaceuticals announces the FDA nod for SECUADO (asenapine) transdermal patch for the treatment of adults with schizophrenia. More news on: Hisamitsu Pharmaceutical Co., Inc., Allergan plc, Merck & Co., Inc., Healthcare ...

Merger activity decreased last week, with one new deal announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Ra Pharmaceuticals ([[RARX]]) by UCB for $2.1 billion, or $48.00 per share in cash. Deal Updates: On October 8, 2019, Prosperity Bancs...

Quick Take 89bio ( ETNB ) has filed to raise gross proceeds of $70 million from a U.S. IPO, according to an S-1 registration statement . The firm is focused on developing and commercializing treatments for liver and cardio-metabolic diseases. ETNB plans to start Phase 2 trials in 2020 a...